BioMarin Pharmaceutical (BMRN) News Today $58.86 -0.96 (-1.60%) As of 05/9/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMRN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Shareholders Will Be Pleased With The Quality of BioMarin Pharmaceutical's (NASDAQ:BMRN) EarningsMay 10 at 10:58 PM | uk.finance.yahoo.comClearline Capital LP Purchases 57,710 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Clearline Capital LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 18.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 377,482 shares of the biotechnology company's sMay 10 at 7:43 AM | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 10 at 6:24 AM | finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Position Lowered by Balyasny Asset Management L.P.Balyasny Asset Management L.P. trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 64.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 337,103 shares of the biotechnology company'sMay 10 at 5:20 AM | marketbeat.comAlgert Global LLC Makes New $2.77 Million Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Algert Global LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 42,095 shares of the biotechnology company's stock, valued at approximately $2,May 10 at 4:56 AM | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Paul Singer’s Stock Picks with Huge Upside PotentialMay 9 at 6:26 AM | insidermonkey.comBayesian Capital Management LP Sells 9,722 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Bayesian Capital Management LP lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 46.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,100 shares of the biotechnology company'sMay 8 at 5:28 AM | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Stocks That Will Make You Rich In 3 YearsMay 7, 2025 | msn.comBioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $104.00 at The Goldman Sachs GroupThe Goldman Sachs Group cut their price objective on shares of BioMarin Pharmaceutical from $124.00 to $104.00 and set a "buy" rating for the company in a research report on Monday.May 7, 2025 | marketbeat.comCristin Hubbard Sells 273 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) StockMay 7, 2025 | insidertrades.comThe Manufacturers Life Insurance Company Has $10.14 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)The Manufacturers Life Insurance Company trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 3.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 154,296 shares of the biotechnology company's stoMay 7, 2025 | marketbeat.comBeacon Pointe Advisors LLC Sells 4,906 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Beacon Pointe Advisors LLC trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 46.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,764 shares of the biotechnology company's stock after selling 4,906May 7, 2025 | marketbeat.comThe Goldman Sachs Group Lowers BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $104.00May 7, 2025 | americanbankingnews.comAxa S.A. Has $37.57 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Axa S.A. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 571,538 shares of the biotechnology company's stock after purchasing an adMay 6, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Northern Trust CorpNorthern Trust Corp grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 16.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,725,039 shares of the biotechnology company'sMay 6, 2025 | marketbeat.comFY2025 EPS Estimates for BMRN Boosted by Cantor FitzgeraldBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2025 EPS estimates for BioMarin Pharmaceutical in a note issued to investors on Friday, May 2nd. Cantor Fitzgerald analyst O. Brayer now forecasts that the biotechnology company wilMay 6, 2025 | marketbeat.comEquities Analysts Issue Forecasts for BMRN FY2025 EarningsMay 5, 2025 | americanbankingnews.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call TranscriptMay 3, 2025 | msn.comAQR Capital Management LLC Buys 685,099 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)AQR Capital Management LLC raised its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 114.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,283,599 sharesMay 3, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,152,913 shares of the biotechnology company's stock after selling 186,8May 3, 2025 | marketbeat.com4BMRN : A Look Into Biomarin Pharmaceutical Inc's Price Over EarningsMay 2, 2025 | benzinga.comBioMarin Pharmaceutical (NASDAQ:BMRN) Beats Q1 Sales TargetsMay 2, 2025 | msn.comPrice T Rowe Associates Inc. MD Has $38.94 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Price T Rowe Associates Inc. MD reduced its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 592,393 shares of tMay 2, 2025 | marketbeat.comQ1 2025 BioMarin Pharmaceutical Inc Earnings Call TranscriptMay 2, 2025 | gurufocus.comBioMarin Pharmaceutical Inc. (BMRN) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comBioMarin Pharmaceutical Inc. 2025 Q1 - Results - Earnings Call PresentationMay 1, 2025 | seekingalpha.comBioMarin Reports First Quarter 2025 Results and Reaffirms Full-year GuidanceMay 1, 2025 | prnewswire.comPDT Partners LLC Raises Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)PDT Partners LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 168.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,663 shares of the biotechnology company's stock after purchaMay 1, 2025 | marketbeat.comWhat To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 EarningsApril 30, 2025 | finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Hsbc Holdings PLCHsbc Holdings PLC trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,530 shares of the biotechnology compApril 30, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside PotentialApril 29, 2025 | insidermonkey.comSusquehanna Fundamental Investments LLC Buys New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Susquehanna Fundamental Investments LLC bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 169,479 shares of the biotechnology compaApril 29, 2025 | marketbeat.comJump Financial LLC Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Jump Financial LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 77.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,431 shares of the biotApril 29, 2025 | marketbeat.comEnvestnet Asset Management Inc. Reduces Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Envestnet Asset Management Inc. reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 14.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,121 shares of the biotechnology company's stoApril 28, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Nebula Research & Development LLCNebula Research & Development LLC cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 18.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 43,185 shares of the biotechnology company's stock after selling 9,514 shares duApril 27, 2025 | marketbeat.com7,908 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Syon Capital LLCSyon Capital LLC purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 7,908 shares of the biotechnology company's stocApril 27, 2025 | marketbeat.comTower Research Capital LLC TRC Acquires 13,426 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Tower Research Capital LLC TRC grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 376.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 16,992 shares of the biotechnology company's stock after purchasinApril 27, 2025 | marketbeat.comCredit Industriel ET Commercial Invests $2.30 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Credit Industriel ET Commercial acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 35,013 shares of the biotechnology company's stock, valued at approximately $April 26, 2025 | marketbeat.comFirst Trust Advisors LP Has $41.41 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)First Trust Advisors LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 34.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 629,985 shares of the biotechnology company's stocApril 26, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by AnalystsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-four analysts that are covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy ratApril 26, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Position Lifted by MetLife Investment Management LLCMetLife Investment Management LLC lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 107,403 shares of the biotechnoApril 25, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Has $3.65 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)J. Safra Sarasin Holding AG decreased its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 55,472 shares oApril 24, 2025 | marketbeat.com4,531 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Forum Financial Management LPForum Financial Management LP acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,531 shares ofApril 24, 2025 | marketbeat.comCANADA LIFE ASSURANCE Co Has $11.23 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)CANADA LIFE ASSURANCE Co reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 19.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 171,018 shares of theApril 24, 2025 | marketbeat.comBMRN Quantitative Stock Analysis - Benjamin GrahamApril 24, 2025 | nasdaq.comBioMarin Pharmaceutical Inc. (BMRN): Among Takeover Rumors Hedge Funds Are BuyingApril 24, 2025 | msn.comImplied Volatility Surging for BioMarin Stock OptionsApril 23, 2025 | msn.comAvoro Capital Advisors LLC Sells 575,515 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Avoro Capital Advisors LLC lowered its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 28.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,462,500 shares of the biotechnology company's stock after selling 575,515 sharApril 23, 2025 | marketbeat.comTownsquare Capital LLC Invests $296,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Townsquare Capital LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,501 shares of the biotechnology company'sApril 23, 2025 | marketbeat.comCapital Research Global Investors Boosts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Capital Research Global Investors raised its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 23.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,991,772 shares ofApril 22, 2025 | marketbeat.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.070.87▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼2211▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today EXEL News Today NBIX News Today EXAS News Today RGEN News Today HALO News Today MDGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy bmrn Stock Free bmrn Stock Alerts